Multicenter, Randomized, Parallel Group Study to Investigate the Optimal Deposition Site for Inhaled Prolastin® in Patients With Cystic Fibrosis (CF)

Trial Profile

Multicenter, Randomized, Parallel Group Study to Investigate the Optimal Deposition Site for Inhaled Prolastin® in Patients With Cystic Fibrosis (CF)

Completed
Phase of Trial: Phase II

Latest Information Update: 15 May 2014

At a glance

  • Drugs Alpha 1-antitrypsin (Primary) ; Alpha 1 antitrypsin modulators
  • Indications Cystic fibrosis
  • Focus Therapeutic Use
  • Sponsors Grifols
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top